跳至主要内容
临床试验/NCT05003726
NCT05003726已完成不适用

Comparative Effectiveness of Non-pharmacological Treatment and Pharmacological Treatment for Non-acute Lumbar Disc Herniation : a Multi-centered, Pragmatic Randomized Controlled, Parallel-grouped Pilot Study

Jaseng Hospital of Korean Medicine4 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2021年10月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
36
试验地点
4
主要终点
Oswestry disability index (ODI)

研究概览

简要总结

This study is a 2-armed parallel, multi-centered, pragmatic clinical trial that compares the comparative effectiveness of non-pharmacological treatment and pharmacological treatment for non-acute lumbar disc herniation.

详细描述

This study is a multi-centered, pragmatic clinical trial that compares the comparative effectiveness of non-pharmacological treatment and pharmacological treatment for non-acute lumbar disc herniation. The participants who voluntarily signed informed consent will be randomly assigned in 1:2 ratio to non-pharmacological group and pharmacological group and will receive the 8 weeks of intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
19 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Numeric rating scale (NRS) score of radiating pain or low back pain 5 or more for recent 3 serial days.
  • Onset time of radiating pain occurred 3 months before enrollment.
  • Radiologically diagnosed with lumbar disc herniation in lumbar spine magnetic resonance imaging (L-spine MRI), which can explain lower extremity radiation pain and back pain
  • 19-69 years old
  • participants who agreed and signed informed consent form

排除标准

  • Spine metastasis of cancer, acute fracture of spine, or spine dislocation
  • Progressive neurologic deficits or severe neurologic deficits
  • Soft tissue diseases that can induce low back pain(ie. cancer, fibromyalgia, rheumatoid arthritis, gout,etc)
  • Presence of chronic underlying disease which can interfere the efficacy or interpretation (ie. stroke, myocardial infarct, kidney disease, dementia, diabetic neuropathy, epilepsy, etc)
  • Concurrent use of steroids, immunosuppressants, orpsychotropic medications or any other medication that can interrupt the study result
  • Hemorrhagic disease, severe diabetes or taking anticoagulant drug
  • Participants who took NSAIDs within 1 week
  • Pregnant or lactating women
  • Participants who had undergone lumbar surgery within 3 months
  • Participants who had participated in other clinical trial within 1 month, or have plan for participation in other trial during follow up period of this trial
  • Participants who can not write informed consent
  • Participants who is difficult to participate in the trial according to investigator's decision

结局指标

主要结局

Oswestry disability index (ODI)

时间窗: week 1, 5, 9, 14, 27

ODI is a functional disability questionnaire. The possible range of eachitem score is 0 to 5. Total score range is 0 (better outcome) to 100 (worse outcome)

次要结局

  • Visual analogue scale (VAS) of low back pain and radiating pain in lower extermities(week 1, 2, 3, 4, 5, 6, 7, 8, 9, 14, 27)
  • Numeric rating scale (NRS) of radiating pain in lower extremities(week -1, 1, 2, 3, 4, 5, 6, 7, 8, 9, 14, 27)
  • Short form-12 health survey version 2 (SF-12 v2)(week 1, 5, 9, 14, 27)
  • Evaluation question(week 1, 2, 3, 4, 5, 6, 7, 8, 9, 14, 27)
  • Drug Consumption(week -1, 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 14, 27)
  • Adverse events(week -1, 1, 2, 3, 4, 5, 6, 7, 8, 9, 14, 27)
  • Numeric rating scale (NRS) of low back pain(week 1, 2, 3, 4, 5, 6, 7, 8, 9, 14, 27)
  • EuroQol-5 Dimension (EQ-5D-5L)(week 1, 5, 9, 14, 27)
  • Credibility and Expectancy(week -1)
  • Patient global impression of change (PGIC)(week 9, 14, 27)

研究者

发起方
Jaseng Hospital of Korean Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kyoung Sun Park

Chief, clinical study center

Jaseng Hospital of Korean Medicine

研究点 (4)

Loading locations...

相似试验